My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Amgen (NQ:AMGN)

375.50 -4.23 (-1.11%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Amgen

< Previous 1 2

...

23 24 25 26 27 28 29 30 31

...

64 65 Next >

4 Oversold Large Cap Stocks Yielding High Dividends

March 14, 2024

Overlooked, oversold large-cap stocks offer compelling dividend yields for investors seeking income and potential capital appreciation

Via MarketBeat

Topics Artificial Intelligence Economy

Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields ↗

March 13, 2024

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...

Via Benzinga

The Dow’s Best Friends: 3 ‘Dogs’ Ready to Fetch Huge Returns ↗

March 11, 2024

The Dogs of the Dow strategy is one of the best yearly strategies investors should use to make some good money.

Via InvestorPlace

Topics Stocks

Obesity Drugs 2024: The Skinny on the Top 3 Weight-Loss Stocks ↗

March 10, 2024

With therapeutics focused on slimming down skyrocketing, it’s time to consider these top weight-loss stocks.

Via InvestorPlace

The AI Race Gets Litigious ↗

March 09, 2024

We've also got a look at the role of patents in pharmaceuticals and the "patent cliff" looming over the next decade.

Via The Motley Fool

Topics Artificial Intelligence Intellectual Property

(AMGN) - Analyzing Amgen's Short Interest ↗

March 06, 2024

Via Benzinga

Amgen Options Trading: A Deep Dive into Market Sentiment ↗

February 23, 2024

Via Benzinga

9 Health Care Stocks Whale Activity In Today's Session ↗

March 08, 2024

Via Benzinga

Medicare's Ambitious Drug Price Negotiation Plan: President Joe Biden Calls To Expand Targeted Medicines To 50 Annually by 2029 ↗

March 07, 2024

Explore President Biden's plan to expand Medicare drug negotiations, targeting at least 50 drugs annually. Uncover the impact on pharmaceutical profits and the broader health-care policy proposals,...

Via Benzinga

Is It Time to Buy February's 3 Worst-Performing Dow Jones Stocks? ↗

March 06, 2024

It's only a bargain price if it's actually worth owning.

Via The Motley Fool

Topics Stocks

It’s Time! 3 Dodgy Pharma Stocks to Sell in February ↗

March 04, 2024

Explore pharma stocks to sell in February: Eli Lilly, Amgen, BioNTech face overvaluation, volatility, urging investor action.

Via InvestorPlace

After Soaring 222% in 1 Day, Is Janux Therapeutics Stock a Buy? ↗

March 02, 2024

The biotech tantalized investors with a very promising data update.

Via The Motley Fool

This Is What Whales Are Betting On Amgen ↗

February 15, 2024

Via Benzinga

Behind the Scenes of Amgen's Latest Options Trends ↗

February 12, 2024

Via Benzinga

Eli Lilly Stock And The Road To 1,000: Weight-Loss Drugs Could Generate $81 Billion ↗

March 01, 2024

Wall Street isn't properly taking into account Lilly's next-generation drugs, an analyst says.

Via Investor's Business Daily

Apple Sinks After Wall Street Titan Pulls Magnificent 7 Stock From Conviction List ↗

March 01, 2024

Goldman Sachs is removing Apple from its Conviction List of buy-rated stocks. Looking at the potential reasons why and who replaced the tech giant.

Via Benzinga

Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields ↗

March 01, 2024

Via Benzinga

2 Stocks That Could Turn $1,000 Into $2,500 in 5 Years ↗

March 01, 2024

It will take a lot, but this goal isn't out of reach for these stocks.

Via The Motley Fool

Better Dividend Growth Stock: AbbVie or Amgen? ↗

February 29, 2024

A strong case can be made for owning both of these dividend growth stocks. But one of them is the better buy.

Via The Motley Fool

Amazon Stock: Why it's Finally Included in the Dow Index

February 29, 2024

Amazon replaced Walgreens in the Dow. While a positive move for Amazon, any impact on the stock's price may be limited due to low index weighting.

Via MarketBeat

Topics Economy Stocks

Amgen's Upcoming Catalysts In 2024 Set To Unlock Multi-Billion Dollar Markets, Says Goldman Sachs ↗

February 26, 2024

Amgen's growth outlook in 2024, with updates on key programs and upcoming catalysts. Goldman Sachs sees significant opportunities despite exclusivity losses. Dive into potential market moves and...

Via Benzinga

3 Biotech Stocks to Buy and Hold for the Next 10 Years ↗

February 26, 2024

There's a lot to like about these three drugmakers right now, and that shouldn't stop anytime soon.

Via The Motley Fool

Weight-Loss Drugs Have One Big Problem. These Drugmakers Are Taking It On. ↗

February 23, 2024

Weight-loss drugs from Novo Nordisk and Eli Lilly lead to massive weight loss. But not all of that weight loss is healthy.

Via Investor's Business Daily

3 Biotech Stocks to Turn $10,000 Into $1 Million: February 2024 ↗

February 22, 2024

With new innovation and high demand, biotech stocks could offer some of the most explosive opportunities of the year.

Via InvestorPlace

If You Invested $20,000 in Amgen in 2014, This Is How Much You Would Have Today ↗

February 17, 2024

Has Amgen been a market-beating stock?

Via The Motley Fool

7 Contrarian Biotech Stocks to Consider Amid Sector Weakness ↗

February 15, 2024

Although the healthcare innovation space has struggled recently, these contrarian biotech stocks now offer compelling discounts.

Via InvestorPlace

7 Must-Buy Pharma Stocks Amid the Weight Loss Drug Revolution ↗

February 14, 2024

Obesity drug sales boomed in 2023 and will continue in 2024. That could make these weight loss stocks even more attractive.

Via InvestorPlace

2 Dow Jones Dividend Stocks With Above-Average Yields to Buy Now and Hold for at Least a Decade ↗

February 14, 2024

Investors interested in a steadily rising stream of passive income will find what they're looking for with these dividend payers.

Via The Motley Fool

Topics Stocks

Amgen Takes Aim at Novo Nordisk and Eli Lilly, but Is the Stock a Buy? ↗

February 14, 2024

It faces both clinical and competitive barriers, but they might not matter.

Via The Motley Fool

Drivers And Stock Pickers ↗

February 13, 2024

As opposed to drivers who overestimate themselves, we seek to be above-average stock pickers by doing the things that most professional investors struggle with, like being courageous and patient.

Via Talk Markets

< Previous 1 2

...

23 24 25 26 27 28 29 30 31

...

64 65 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.